Concepedia

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma

Hye Ryun Kim, Seungtaek Lim, H. J. Kim, Soohyun Hwang, J. K. Park, Eun‐Joo Shin, M. Bae, S.-H.I. Ou, J. Wang, Susan Jewell,

Annals of Oncology · 2013 · 123 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer

Klarisa Rikova, Ailan Guo, Qingfu Zeng et al. · Cell · 2007 · 2.3K citations · Full text

, , +7

<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations

, , +4

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak et al. · The Lancet Oncology · 2012 · 1.3K citations · Full text

, , +10

Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers

Ramaswamy Govindan, Li Ding, Malachi Griffith et al. · Cell · 2012 · 1.2K citations · Full text

, , +7